Paul Sugarbaker, MD, is the medical director for the Center for Gastrointestinal Malignancies at MedStar Washington Hospital Center. Acknowledged as a national and international expert in surgical oncology, Dr. Sugarbaker is a mentor and an investigator. He is best known for his expertise in gastrointestinal surgical oncology for rare diseases, such as pseudomyxoma peritonei, peritoneal mesothelioma, abdominal sarcomas and peritoneal carcinomatosis from colorectal cancers.
He has pioneered highly specialized treatment procedures, such as cytoreductive surgery with heated intraoperative intraperitoneal chemotherapy (HIPEC). This treatment, known as the Sugarbaker procedure, was featured in The Washington Post("Surgeon performs controversial cancer surgery named after him," Nov. 25, 2012, by Del Quentin Wilber).
Dr. Sugarbaker has published more than 800 scientific articles and book chapters. Additionally, he has written numerous textbooks. His textbook on sarcoma surgery has been translated into five languages. Most recently, he published a textbook and video atlas entitled "Cytoreductive Surgery and Perioperative Chemotherapy for Peritoneal Surface Malignancy."
He has lectured extensively, both nationally and internationally, earning numerous awards and citations. He is a fellow of The Royal College of Surgeons of England and The Royal College of Physicians and Surgeons of Glasgow, Scotland. He received the Distinguished Service Award from the American Society of Abdominal Surgeons. He serves on the editorial boards of eleven journals and is a member of numerous professional societies, including the American College of Surgeons, Society of Surgical Oncology, European Society of Surgical Oncology and the American Surgical Association. He is a founding member of the International Society of Regional Cancer Therapy.
Dr. Sugarbaker earned his medical degree from Cornell University Medical College and a Master of Science degree in Basic Sciences from Harvard Graduate School of Arts and Sciences. His training in surgery took place at the Peter Bent Brigham Hospital, Boston, now the Brigham and Women's Hospital. He spent 10 years as a senior surgeon at the National Institutes of Health, National Cancer Institute, Surgery Branch. He was appointed the medical director of the Washington Cancer Institute at MedStar Washington Hospital Center in 1989.
During his 23 years as an attending surgical oncologist at the Hospital Center, he performed approximately 1,500 cytoreductive surgeries combined with HIPEC for patients with diagnoses of gastrointestinal cancers, such as appendix, colon, peritoneal mesothelioma, ovarian, small bowel and unknown primary.
Dr. Sugarbaker's research interests include
- Gastrointestinal surgical oncology
- Colorectal cancer
- Perioperative intraperitoneal and intravenous chemotherapy
- Cytoreductive surgery
- Peritoneal metastases
- Appendix cancer
- Pseudomyxoma peritonei
- Peritoneal surface malignancies
- Research Areas